Description
In September 2011, Lilly launched The Lilly NCD Partnership, which combines the company's unique resources with the expertise of leading global health
organizations, to identify new models of patient care that increase treatment access and improve outcomes for underserved people. The partnership will initially focus on diabetes – a core business area in which Lilly has deep expertise.
Non-communicable diseases (NCDs), known as chronic diseases, include cardiovascular diseases, diabetes, cancer and chronic respiratory diseases. The first phase of The Lilly NCD Partnership will focus on improving
diabetes care in targeted communities in Brazil, India, Mexico and South Africa.
Lilly and its partners continue to develop country-specific programs that will launch in early 2012. Lilly and its partners will develop country-specific milestones that, if achieved, will trigger future investments. Partners include:
Brazil: Hospital Israelita Albert Einstein – Diagnostic &
Preventive Medicine and Research Institute
India: The Public Health Foundation of India, Project
HOPE, Population Services International
Mexico: The Carlos Slim Health Institute – Casalud
South Africa: The Donald Woods Foundation, Project
HOPE
Results
Leveraging the company's business model, the Lilly NCD Partnership will use the following methodology:
Research: Pilot models of healthcare for diabetes based
on sophisticated research and detailed data collection.
Report: Work with well-respected partners to share data
and key learnings.
Advocate: Inform key stakeholders about program
findings and encourage adoption of proven, cost-
effective solutions.